On a Mission to End Diabetes
Diabetes is the seventh-leading cause of death in the United States. The Diabetes Group at Sanford Research aims to fight this public health threat by researching type 1 and gestational diabetes.
We have a special interest in type 1 diabetes with The Sanford Project, an initiative to cure type 1 diabetes – the type that typically affects children.
We plan to end type 1 diabetes through discovery in three key areas:
- Autoimmunity: stopping the immune system’s attack on the body’s insulin-producing beta cells
- Prevention: identifying children at high risk and intervening before the onset of autoimmunity
- Regeneration: harnessing advancements in regenerative medicine to stimulate repair mechanisms and reboot insulin-producing beta cells
Our comprehensive strategy promises faster progress toward improving diabetes patients’ lives.
The Diabetes research group supports:
Primary Faculty
Secondary Faculty
Sanford Health News
-
background-image
Sen. Tina Smith convenes roundtable at Sanford Bemidji
Providers, policymakers talk expanding access to maternal health care
-
background-image
Sanford patient is first in US to test new cancer treatment
Immunotherapy clinical trial starts in Midwest, could benefit cancer patients everywhere
Classes & Events
-
background-image
Teen Science Café
Tue 10/03/23 5:30 PM - Tue 10/03/23 7:00 PM
Sanford PROMISE Community Lab -
background-image
Sanford PROMISE Biomedical Research Investigation Days
Mon 10/09/23 9:30 AM - Mon 10/09/23 4:00 AM
Sanford PROMISE Community Lab